The newswire reported that PCI’s private equity owner had asked bank RBC Capital Markets to find potential buyers last night, citing “people familiar with the matter.”
PCI was established in 2012 after current majority owner Frazer Healthcare Partners bought Catalent Pharma Solutions’s packaging operations.
The firms other backers include QIC Global Private Equity, Greenspring Associates and Thomas, McNerney & Partners.
In the years since Frazier has expanded the business. In 2013, it bought AndersonBrecon, the packaging subsidiary of AmerisourceBergen, for $308m (€229m).
A year later it acquired Tredegar, Wales based contract development and manufacturing services firm Penn Pharmaceutical Services for £127m ($215m)
Also in 2014 PCI bought packaging and distribution firm Biotec Services International – based in Bridgend, Wales - citing demand for cold chain services from a growing injectable pharmaceutical market as the driver.
Frazier did not respond to a request for comment about the Reuters report.